Download Files:
ER21355
SKU
HY-101826-Get quote
Category Reference compound
Tags Cancer, Metabolic Enzyme/Protease, Phosphodiesterase (PDE)
Products Details
Product Description
– ER21355 is an inhibitor of phosphodiesterase 5 (PDE5), used for treatment of prostatic diseases.
Web ID
– HY-101826
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C22H21ClN4O4
References
– [1]Wolf-Georg Forssmann, et al. Use of phosphodiesterase inhibitors in the treatment of prostatic diseases. US 8106061 B2
CAS Number
– 150452-18-9
Molecular Weight
– 440.88
SMILES
– O=C(C1CCN(C2=NC(NCC3=CC=C(OCO4)C4=C3)=C5C=C(Cl)C=CC5=N2)CC1)O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Phosphodiesterase (PDE)
Isoform
– PDE5
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.